1. Pancreatic neuroendocrine tumor: Correlations between MRI features, tumor biology, and clinical outcome after surgery
   Rodrigo Canellas et al, 2018, J. Magn. Reson. Imaging CrossRef
2. CLEC3A, MMP7, and LCN2 as novel markers for predicting recurrence in resected G1 and G2 pancreatic neuroendocrine tumors
   Masami Miki et al, 2019, Cancer Med CrossRef
3. Microenvironment and tumor inflammatory features improve prognostic prediction in gastro‐entero‐pancreatic neuroendocrine neoplasms
   Massimo Milione et al, 2019, J Pathol Clin Res CrossRef
4. Clinical applications of (epi)genetics in gastroenteropancreatic neuroendocrine neoplasms: Moving towards liquid biopsies
   Gitta Boons et al, 2019, Rev Endocr Metab Disord CrossRef
5. Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies
   Lingaku Lee et al, 2019, Expert Review of Anticancer Therapy CrossRef
6. Identification of novel serum autoantibodies against EID3 in non-functional pancreatic neuroendocrine tumors
   Koji Hontani et al, 2017, Oncotarget CrossRef
7. Molecular targeting of cell-permeable peptide inhibits pancreatic ductal adenocarcinoma cell proliferation
   Shoki Sato et al, 2017, Oncotarget CrossRef
8. Prognostic Significance of Altered ATRX/DAXX Gene in Pancreatic Neuroendocrine Tumors: A Meta-Analysis.
   Fei Wang et al, 2021, Front Endocrinol (Lausanne) CrossRef
9. Serum Inflammation-based Scores in Endocrine Tumors
   Pedro Marques et al, 2021 CrossRef
10. Analysis of Immune Landscape in Pancreatic and Ileal Neuroendocrine Tumours Demonstrates an Immune Cold Tumour Microenvironment
    Lulu Tanno et al, 2022, Neuroendocrinology CrossRef
11. Role of Tumor-Associated Macrophages in the Clinical Course of Pancreatic Neuroendocrine Tumors (PanNETs).
    Lei Cai et al, 2019, Clin Cancer Res CrossRef
12. The Landscape and Clinical Application of the Tumor Microenvironment in Gastroenteropancreatic Neuroendocrine Neoplasms
    Shuaishuai Xu et al, 2022, Cancers CrossRef
13. Tumour Heterogeneity and the Consequent Practical Challenges in the Management of Gastroenteropancreatic Neuroendocrine Neoplasms
    Isabella Reccia et al, 2023, Cancers CrossRef
14. The Clinical Impact of Death Domain-Associated Protein and Holliday Junction Recognition Protein Expression in Cancer: Unmasking the Driving Forces of Neoplasia
    Alexandros Pergaris et al, 2023, Cancers CrossRef
15. Defining Tumor Microenvironment as a Possible Target for Effective GEP-NENs Immunotherapy—A Systematic Review
    Paulina Chmiel et al, 2023, Cancers CrossRef